New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2012
07:42 EDTINSM, IART, PBTH, AHS, CPHD, BIOS, ARNA, CLDX, USPH, DXCMOppenheimer to host a conference
23rd Annual Healthcare Conference is being held in New York on December 12-13 with webcasted presentations to begin on December 12 at 7:45 am; not all company presentations may be webcasted. Webcast Link
Sign up for a free trial to see the rest of the stories you've been missing.
March 31, 2015
09:01 EDTINSMInsmed 10M share Spot Secondary priced at $20.65
Subscribe for More Information
March 30, 2015
18:51 EDTINSMOn The Fly: After Hours Movers
Subscribe for More Information
16:21 EDTINSMInsmed files to sell 10M shares of common stock
Subscribe for More Information
March 26, 2015
10:04 EDTUSPHOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:25 EDTUSPHU.S. Physical Therapy initiated with a Market Perform at Barrington
Subscribe for More Information
March 25, 2015
13:42 EDTIARTIntegra LifeSciences price target raised to $72 from $61 at Argus
Subscribe for More Information
07:29 EDTIARTLeerink to hold booth tours
Leerink Booth Tours at AAOS 2015 will be held in Las Vegas on March 25-26.
March 24, 2015
16:09 EDTCPHDCepheid receives FDA emergency use authorization for Xpert Ebola diagnostic test
Cepheid announced it has received Emergency Use Authorization from the FDA for Xpert Ebola, a molecular diagnostic test for Ebola Zaire Virus that delivers results in less than two hours. The test runs on the Cepheid GeneXpert Systems. Xpert Ebola has been authorized by FDA under an Emergency Use Authorization for use by CLIA moderate and high complexity laboratories or similarly qualified non-U.S. laboratories. The test will begin shipping in April. Cepheid's Xpert Ebola has not been FDA cleared or approved, but will remain available in the U.S. as an EUA product as long as the declared emergency remains in effect or it ceases to be authorized by FDA.
13:54 EDTINSMInsmed personnel strong, says Piper Jaffray
After attending Insmed's analyst event, Piper says that the company has assembled a strong development and commercial team . The firm adds that the company has forged unique relationships with specialists and patients. It keeps an Overweight rating on the shares.
10:01 EDTAHSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:54 EDTAHSAMN Healthcare upgraded to Buy from Neutral at UBS
UBS upgraded AMN Healthcare Services to Buy after meeting with management and raised its price target for shares to $27 from $21.50. The firm believes an improving economy and healthcare reform are driving "robust" demand for AMN's services.
March 23, 2015
09:47 EDTBIOSBioScrip management to meet with Barrington
Meeting to be held in Minneapolis on March 30 hosted by Barrington.
09:06 EDTINSMInsmed appoints Eugene Sullivan as Chief Medical and Scientific Officer
Subscribe for More Information
07:28 EDTAHSAMN Healthcare management to meet with UBS
Subscribe for More Information
March 20, 2015
10:25 EDTBIOSBioScrip management to meet with SunTrust
Meetings to be held in New York on March 24 and in Boston on March 25 hosted by SunTrust.
09:25 EDTINSMInsmed to host analyst and investor day
Subscribe for More Information
March 19, 2015
17:30 EDTBIOSColiseum Capital reports 18.6% stake in BioScrip
08:57 EDTCPHDCepheid has a conference call hosted by JPMorgan
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use